MeSH D008059 - mucopolysaccharidosis i
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| BioMarin Pharmaceutical | Laronidase | Aldurazyme | 2003-04-30 | $132.107 M | Q2/23-Q1/24 | |
| Sanofi | Laronidase | Aldurazyme | 2003-06-09 |
Clinical Trials
Historical Success Rate
Phase 1
75%6/8
Phase 2
14%2/14
Phase 3
75%3/4
Approved: 2Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use